The thalassemic red cell membrane
- PMID: 1298998
The thalassemic red cell membrane
Abstract
The underlying cause of pathology in thalassemia is the premature destruction of red cells, both in the bone marrow and by the reticuloendothelial system. It is generally accepted that the presence of unpaired excess globin chains is the primary circumstance leading to such membrane alterations as oxidation of phospholipids, modification of cytoskeletal proteins and their interactions, reduced membrane-associated ATPase activities, and enhanced permeability of cations. Such perturbations in turn result in the exposure of outer surface neoantigens, enhanced binding of autoantibodies and complement fixation to the outer red cell surface. These factors contribute to the observed distinctive morphologies, increased rigidity and decreased deformability of the thalassemic red cells. In alpha-thalassemic red cells, excess beta-globin chains form homotetramers, Hb H, which are relatively stable and will only damage red cell membrane when precipitated as inclusion bodies, whereas excess alpha-globin chains cannot form such homotetramers and upon synthesis rapidly bind to the cytoplasmic side of the beta-thalassemic red cell membrane, even in young erythroblasts. This difference in properties of the excess globin chains may offer an explanation for the variation in clinical severity observed between these two forms of thalassemia.
Similar articles
-
Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia.Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:257-60. Southeast Asian J Trop Med Public Health. 1995. PMID: 8629118
-
Phospholipid composition and organization in model beta-thalassemic erythrocytes.Am J Hematol. 1996 Jan;51(1):45-54. doi: 10.1002/(SICI)1096-8652(199601)51:1<45::AID-AJH8>3.0.CO;2-7. Am J Hematol. 1996. PMID: 8571937
-
Biophysical changes of red cells with thalassemia-like abnormal hemoglobin.Southeast Asian J Trop Med Public Health. 1992;23 Suppl 2:86-90. Southeast Asian J Trop Med Public Health. 1992. PMID: 1299000
-
Thalassemia: pathophysiology of red cell changes.Annu Rev Med. 1994;45:211-8. doi: 10.1146/annurev.med.45.1.211. Annu Rev Med. 1994. PMID: 8198378 Review.
-
Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia.Hemoglobin. 2008;32(4):327-49. doi: 10.1080/03630260802173833. Hemoglobin. 2008. PMID: 18654884 Review.
Cited by
-
Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk.Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251359291. doi: 10.1177/10760296251359291. Epub 2025 Jul 14. Clin Appl Thromb Hemost. 2025. PMID: 40660796 Free PMC article.
-
Protein C and S levels in patients with Thalassemia intermedia.J Med Life. 2022 Nov;15(11):1415-1418. doi: 10.25122/jml-2021-0316. J Med Life. 2022. PMID: 36567848 Free PMC article.
-
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver.Nat Med. 2016 Aug;22(8):945-51. doi: 10.1038/nm.4146. Epub 2016 Jul 18. Nat Med. 2016. PMID: 27428900 Free PMC article.
-
CD47 in Erythrocyte Ageing and Clearance - the Dutch Point of View.Transfus Med Hemother. 2012 Oct;39(5):348-52. doi: 10.1159/000342231. Epub 2012 Sep 6. Transfus Med Hemother. 2012. PMID: 23801927 Free PMC article.
-
Protein C and Anti-Thrombin-III Deficiency in Children With Beta-Thalassemia.J Hematol. 2018 May;7(2):62-68. doi: 10.14740/jh392w. Epub 2018 May 10. J Hematol. 2018. PMID: 32300414 Free PMC article.